Literature DB >> 2894880

Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats.

S M Gardiner1, T Bennett.   

Abstract

1. Intra-arterial blood pressures and heart rates were recorded in conscious, unrestrained, Long Evans and Brattleboro rats receiving sequential, continuous administrations of selective alpha 1- (prazosin) and alpha 2- (idazoxan) adrenoceptor antagonists. The same protocols were also run in the presence of ICI 118551 (a selective antagonist of beta 2-adrenoceptors). 2. Prazosin and idazoxan caused large, but transient, hypotensions in Long Evans and Brattleboro rats. In the continued presence of both drugs there were marked, intermittent, depressor episodes and tachycardias in both strains of rat. 3. In the presence of low or high doses of ICI 118551 the hypotensive responses to prazosin and idazoxan were markedly reduced in both strains of rat and blood pressures showed little variability, although intermittent tachycardias still occurred. 4. In adrenal-demedullated Long Evans rats, the hypotensive responses to prazosin and idazoxan were attenuated and in the presence of both drugs, blood pressure was relatively steady, although intermittent tachycardias still occurred. 5. In the presence of prazosin and idazoxan, when a depressor episode was not occurring, administration of captopril caused hypotension in Long Evans and Brattleboro rats. In the latter, the reduction in blood pressure was sustained, whereas there was a recovery in blood pressure in Long Evans rats. This recovery was punctuated by depressor episodes, and was abolished by a V1-receptor antagonist (d(CH2)5DAVP). 6. Long Evans rats given two primed doses of the non-selective alpha-adrenoceptor antagonist, phentolamine, exhibited variation in blood pressure similar to that seen in the presence of prazosin and idazoxan. As in the latter case, blood pressure variability was inhibited by the beta 2-adrenoceptor antagonist, ICI 118551. 7. Administration of idazoxan into a lateral ventricle in Long Evans rats receiving phenoxybenzamine intravenously did not cause blood pressure instability. However, intravenous administration of idazoxan in the same animals produced intermittent depressor episodes and tachycardias similar to those seen in the presence of prazosin and idazoxan. 8. The simplest explanation of the results is that beta 2-adrenoceptor-mediated depressor mechanisms contribute to the hypotensive responses to alpha 1- and alpha 2-adrenoceptor antagonism. Furthermore, in the presence of adequate peripheral alpha 1- and alpha 2-adrenoceptor antagonism, blood pressure may be maintained by the renin-angiotensin system and vasopressin (although it is only when the former system has been antagonized that a clear-cut pressor action of vasopressin is apparent). Under these conditions, blood pressure maintenance is interrupted by intermittent depressor episodes that are largely due to adrenal medullary activation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894880      PMCID: PMC1853781          DOI: 10.1111/j.1476-5381.1988.tb11400.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551).

Authors:  A J Bilski; S E Halliday; J D Fitzgerald; J L Wale
Journal:  J Cardiovasc Pharmacol       Date:  1983 May-Jun       Impact factor: 3.105

2.  On the mechanism of the vasopressin-induced inhibition of renin release.

Authors:  W Knepel; W Reimann; D Nutto
Journal:  Horm Metab Res       Date:  1982-03       Impact factor: 2.936

3.  Systemic arterial hypertension in rats exposed to short-term isolation; intra-arterial systolic and diastolic blood pressure and baroreflex sensitivity.

Authors:  S M Gardiner; T Bennett; P A Kemp
Journal:  Med Biol       Date:  1980-08

4.  Interaction of alpha- and beta-adrenergic receptor blocking agents: circulatory effects in the conscious rat.

Authors:  C Gomes; M Henning; B Persson; G Trolin
Journal:  Clin Exp Hypertens       Date:  1978       Impact factor: 1.749

5.  Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.

Authors:  M Burnier; J Biollaz; D B Brunner; H Gavras; H R Brunner
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

6.  Prejunctional alpha 2-adrenoceptors modulate stimulation-evoked norepinephrine release in rabbit lateral saphenous vein.

Authors:  B Levitt; J P Hieble
Journal:  Eur J Pharmacol       Date:  1986-12-16       Impact factor: 4.432

Review 7.  Evidence for more than one type of post-junctional alpha-adrenoceptor.

Authors:  J C McGrath
Journal:  Biochem Pharmacol       Date:  1982-02-15       Impact factor: 5.858

8.  Blood pressure dependency on vasopressin and angiotensin II in prazosin-treated conscious normotensive rats.

Authors:  B Waeber; J Nussberger; H R Brunner
Journal:  J Pharmacol Exp Ther       Date:  1983-05       Impact factor: 4.030

9.  Phenoxybenzamine is more potent in inactivating alpha 1- than alpha 2-adrenergic receptor binding sites.

Authors:  K P Minneman
Journal:  Eur J Pharmacol       Date:  1983-10-14       Impact factor: 4.432

10.  Selective activation of the adrenal medulla during acute bilateral carotid occlusion and its modulation by alpha-adrenergic receptors in the rat.

Authors:  M Bouvier; J de Champlain
Journal:  Can J Physiol Pharmacol       Date:  1983-04       Impact factor: 2.273

View more
  4 in total

1.  Involvement of beta 2-adrenoceptors in the regional haemodynamic responses to bradykinin in conscious rats.

Authors:  S M Gardiner; P A Kemp; T Bennett; C Bose; R Foulkes; B Hughes
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

2.  Adrenalectomy abolishes antagonism of alpha-adrenoceptor-mediated hypotension by a beta-blocker in conscious rats.

Authors:  R Tabrizchi; C C Pang
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

3.  Regional haemodynamic effects of antagonists of angiotensin II, endothelin and adrenoceptors in conscious, vasopressin-deficient, genetically hypertensive rats.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

4.  Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.